The Discounted Cash Flow (DCF) valuation of ABIOMED Inc (ABMD) is 126.74 USD. With the latest stock price at 381.02 USD, the upside of ABIOMED Inc based on DCF is -66.7%.
Based on the latest price of 381.02 USD and our DCF valuation, ABIOMED Inc (ABMD) is a sell. selling Abiomed stocks now will result in a potential gain of 66.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 7.5% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 80.71 - 336.39 | 126.74 |
| Upside | -78.8% - -11.7% | -66.7% |